Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)
Clinical trial NCT03639623 · COMPLETED
Trial details
- NCT number
- NCT03639623
- Sponsor
- Zydus Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-25
- Primary completion
- 2021-12-13
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.